Electrocardiographic markers predict left ventricular wall motion improvement in patients with acute myocardial

Leonid Berstein1, Alexander Vishnevsky, Vladimir Novikov

  • 1Department of Cardiology, Medical Academy of Postgraduate Studies, Saint-Petersburg, Russia. l_berstein@yahoo.com

Insights

Early prediction of left ventricular wall motion changes in ST-elevation myocardial infarction (STEMI) is crucial. Total ST-segment resolution and T-wave changes after thrombolysis reliably predict improvement in STEMI patients.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Electrocardiography

Background:

  • Prognosis in ST-elevation myocardial infarction (STEMI) depends on early left ventricular wall motion assessment.
  • Fibrinolysis is a key treatment for STEMI, necessitating predictive markers for patient outcomes.

Purpose of the Study:

  • To identify reliable predictors of left ventricular wall motion score index (WMSI) improvement in STEMI patients treated with thrombolysis.
  • To evaluate the utility of ST-segment resolution and T-wave amplitude changes as early prognostic indicators.

Main Methods:

  • Analysis of 106 STEMI patients undergoing thrombolysis.
  • Assessment of total and maximal ST-segment resolution at 3 hours post-thrombolysis.
  • Measurement of T-wave amplitude changes at 48 hours and baseline.

Main Results:

  • Total ST-segment resolution >44% (anterior) and >59% (nonanterior) predicted WMSI improvement.
  • T-wave amplitude difference < -28 mm at 48 hours also predicted WMSI improvement.
  • Specific sensitivities and specificities were reported for these predictive markers.

Conclusions:

  • Total ST-segment resolution at 3 hours is a reliable predictor of WMSI improvement in STEMI.
  • T-wave changes at 48 hours post-thrombolysis also reliably predict left ventricular recovery in STEMI patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...